Up, Up, and Away
A business analyst rated Baxter stock a strong BUY, as the PD market has an attractive growth rate in the range of 5% to 6%, and the option is flexible and allows a more normal life.
Read the full article » | Posted 07-14-2017
Related Articles
- World Conference in Nephrology Videos on Home Dialysis Posted 04-14-2026
- Vantive’s PD Catheter: Timing, Tips, and Techniques Webinar Posted 04-14-2026
- DaVita Has a New PD Loss-predictive AI Model to Identify Patients at Risk Posted 04-14-2026
- ISPD’s Spotlight Webinar Series 2026 Posted 03-12-2026